Potassium Acetate Injection — Class III drug recall D-1585-2020
Terminated recall by Exela Pharma Sciences LLC, reported 2020-09-23, distributed nationwide. Short Fill
| Recall number | D-1585-2020 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Exela Pharma Sciences LLC, Lenoir, NC, United States |
| Recall initiated | 2020-05-05 |
| Classified | 2020-09-14 |
| Reported by FDA | 2020-09-23 |
| Terminated | 2022-01-14 |
| Distributed | Nationwide (US) |
| Quantity | 23,775 vials |
| NDC | 51754-2001-04 |
| Lot numbers | P0000471 |
| Model numbers | 2020TS002 |
| Expiration dates | 2021-04 |
Product
Potassium Acetate Injection, USP 40 mEq/20 mL (2 mEq/mL) Single Dose Vials, Rx only, Manufactured By: Exela Pharma Sciences, LLC. Lenoir, NC NDC 51754-2001-4
Reason for recall
Short Fill
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1585-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.